GSA Capital Partners’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,844
| Closed | -$88K | – | 2041 |
|
|
2025
Q1 | $88K | Buy |
+15,844
| New | +$88K | 0.01% | 1516 |
|
|
2024
Q1 | – | Sell |
-24,515
| Closed | -$226K | – | 1878 |
|
|
2023
Q4 | $226K | Sell |
24,515
-9,503
| -28% | -$87.6K | 0.02% | 1258 |
|
|
2023
Q3 | $206K | Sell |
34,018
-85,472
| -72% | -$518K | 0.02% | 1276 |
|
|
2023
Q2 | $927K | Sell |
119,490
-22,915
| -16% | -$178K | 0.09% | 354 |
|
|
2023
Q1 | $812K | Sell |
142,405
-95,954
| -40% | -$547K | 0.08% | 431 |
|
|
2022
Q4 | $1.4M | Buy |
238,359
+12,759
| +6% | +$75.2K | 0.17% | 80 |
|
|
2022
Q3 | $722K | Buy |
225,600
+174,965
| +346% | +$560K | 0.1% | 326 |
|
|
2022
Q2 | $227K | Buy |
50,635
+8,128
| +19% | +$36.4K | 0.03% | 1008 |
|
|
2022
Q1 | $227K | Buy |
42,507
+18,553
| +77% | +$99.1K | 0.03% | 1096 |
|
|
2021
Q4 | $352K | Buy |
+23,954
| New | +$352K | 0.04% | 828 |
|